X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1755) 1755
Publication (163) 163
Newspaper Article (43) 43
Book Review (40) 40
Newsletter (30) 30
Book Chapter (19) 19
Magazine Article (9) 9
Conference Proceeding (6) 6
Trade Publication Article (2) 2
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1154) 1154
index medicus (811) 811
chondroitin sulfate (627) 627
animals (571) 571
female (558) 558
male (475) 475
osteoarthritis (315) 315
middle aged (312) 312
chondroitin sulfates - therapeutic use (309) 309
chondroitin (292) 292
aged (279) 279
adult (264) 264
heparin - adverse effects (262) 262
sulfates (261) 261
thrombocytopenia - chemically induced (210) 210
heparin (196) 196
glycosaminoglycans (195) 195
treatment outcome (191) 191
glucosamine (188) 188
drug combinations (185) 185
dermatan sulfate - therapeutic use (178) 178
heparitin sulfate - therapeutic use (176) 176
anticoagulants - adverse effects (174) 174
analysis (173) 173
chondroitin sulfates - adverse effects (170) 170
knee osteoarthritis (160) 160
anticoagulants - therapeutic use (156) 156
research (155) 155
pharmacology & pharmacy (153) 153
care and treatment (152) 152
chondroitin sulfates - administration & dosage (139) 139
pregnancy (135) 135
double-blind (132) 132
surgery (132) 132
health aspects (131) 131
rheumatology (129) 129
rats (127) 127
arthritis (126) 126
glucosamine - therapeutic use (126) 126
hyaluronic acid (118) 118
chondroitin sulfates (117) 117
osteoarthritis - drug therapy (117) 117
hematology (114) 114
article (110) 110
collagen (109) 109
dietary supplements (109) 109
mice (107) 107
pain (107) 107
proteins (106) 106
chondroitin sulfates - pharmacology (105) 105
aged, 80 and over (104) 104
chondroitin sulfates - chemistry (103) 103
anticoagulants (101) 101
neurosciences (100) 100
malaria (94) 94
dermatan sulfate (90) 90
in-vitro (89) 89
knee (88) 88
osteoarthritis, knee - drug therapy (87) 87
medicine (86) 86
orthopedics (86) 86
inflammation (85) 85
management (85) 85
proteoglycans (84) 84
biochemistry & molecular biology (83) 83
research article (83) 83
thrombocytopenia - drug therapy (83) 83
medicine, general & internal (81) 81
peripheral vascular disease (80) 80
sulfate (80) 80
expression (79) 79
cartilage (78) 78
heparin-induced thrombocytopenia (78) 78
extracellular matrix (76) 76
adolescent (74) 74
clinical trials (74) 74
antibodies (73) 73
cells, cultured (73) 73
double-blind method (73) 73
efficacy (73) 73
thrombosis (73) 73
therapy (72) 72
adverse clinical events (71) 71
physiological aspects (70) 70
risk factors (70) 70
hyaluronic-acid (67) 67
oversulfated chondroitin sulfate (67) 67
time factors (67) 67
medicine & public health (66) 66
molecular-weight heparin (66) 66
chondroitin sulfates - analysis (65) 65
disease models, animal (65) 65
chondroitin sulfate proteoglycan (64) 64
chondroitin sulfate proteoglycans (64) 64
ophthalmology (64) 64
studies (64) 64
usage (64) 64
engineering, biomedical (63) 63
immunology (63) 63
dermatan sulfate - adverse effects (62) 62
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1737) 1737
German (34) 34
French (31) 31
Russian (15) 15
Japanese (13) 13
Polish (2) 2
Serbian (2) 2
Spanish (2) 2
Arabic (1) 1
Chinese (1) 1
Danish (1) 1
Dutch (1) 1
Hebrew (1) 1
Italian (1) 1
Portuguese (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e24S - e43S
This article describes the pharmacology of approved parenteral anticoagulants. These include the indirect anticoagulants, unfractionated heparin (UFH),... 
RESPIRATORY SYSTEM | CRITICAL CARE MEDICINE | Heparitin Sulfate - adverse effects | United States | Humans | Thrombin - antagonists & inhibitors | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Dose-Response Relationship, Drug | Pipecolic Acids - administration & dosage | Chondroitin Sulfates - adverse effects | Societies, Medical | Pipecolic Acids - adverse effects | Heparitin Sulfate - administration & dosage | Polysaccharides - administration & dosage | Thrombosis - blood | Thrombosis - prevention & control | Dermatan Sulfate - administration & dosage | Dermatan Sulfate - adverse effects | Peptide Fragments - administration & dosage | Polysaccharides - adverse effects | Evidence-Based Medicine | Recombinant Proteins - administration & dosage | Antithrombins - agonists | Chondroitin Sulfates - administration & dosage | Hirudins - adverse effects | Fibrinolytic Agents - administration & dosage | Peptide Fragments - adverse effects | Thrombosis - drug therapy | Heparin, Low-Molecular-Weight - administration & dosage | Infusions, Intravenous | Practice Guidelines as Topic | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2008, Volume 358, Issue 23, pp. 2457 - 2467
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2006, Volume 354, Issue 8, pp. 795 - 808
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 08/2010, Volume 69, Issue 8, pp. 1459 - 1464
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 01/2016, Volume 75, Issue 1, pp. 37 - 44
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2008, Volume 359, Issue 25, pp. 2674 - 2684
Journal Article
European Journal of Obstetrics & Gynecology and Reproductive Biology, ISSN 0301-2115, 2016, Volume 207, pp. 125 - 128
Abstract Objective To assess whether the orally administered combination of hyaluronic acid (HA), chondroitin sulfate (CS), curcumin and quercetin could be... 
Obstetrics and Gynecology | Urinary tract infections | Curcumin | Glycosaminoglycans | Quercetin | Estrogen | MULTICENTER | INTERSTITIAL CYSTITIS | 3-O-BETA-D-GLUCURONIDE | BACTERIAL CYSTITIS | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE BIOLOGY | THERAPY | MICE | METABOLITE | EXPRESSION | Hyaluronic Acid - therapeutic use | Humans | Middle Aged | Secondary Prevention | Urinary Tract Infections - prevention & control | Vaginal Creams, Foams, and Jellies - adverse effects | Estrogens - adverse effects | Urinary Tract Infections - complications | Estrogens - therapeutic use | Vaginal Creams, Foams, and Jellies - therapeutic use | Chondroitin Sulfates - adverse effects | Anti-Infective Agents, Urinary - adverse effects | Aging | Anti-Infective Agents, Urinary - therapeutic use | Postmenopause | Female | Urinary Tract Infections - microbiology | Dietary Supplements - adverse effects | Hyaluronic Acid - adverse effects | Severity of Illness Index | Atrophic Vaginitis - physiopathology | Curcumin - therapeutic use | Quercetin - therapeutic use | Disease Resistance - drug effects | Curcumin - adverse effects | Chondroitin Sulfates - therapeutic use | Combined Modality Therapy - adverse effects | Atrophic Vaginitis - drug therapy | Estrogen Replacement Therapy - adverse effects | Antioxidants - therapeutic use | Estriol - adverse effects | Quercetin - adverse effects | Antioxidants - adverse effects | Estriol - therapeutic use | Urinary Tract Infections - urine | Atrophic Vaginitis - complications | Prevention | Relapse | Postmenopausal women | Sulfates | Hyaluronic acid | Chondroitin | Diseases | Evaluation | Analysis
Journal Article
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 09/2008, Volume 51, Issue 18, pp. 5498 - 5501
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 07/2014, Volume 132, Issue 7, pp. 832 - 837
IMPORTANCE: Optisol-GS, the most common corneal storage medium in the United States, contains antibacterial but no antifungal supplementation. Most... 
VORICONAZOLE | PRESERVATION MEDIUM | DONOR CORNEAS | RIM CULTURES | PENETRATING KERATOPLASTY | ENDOTHELIAL-CELLS | SUSCEPTIBILITY | OPHTHALMOLOGY | FUNGAL ENDOPHTHALMITIS | EYE-BANKING | TRANSPLANTATION | Dextrans - adverse effects | Triazoles - adverse effects | Antifungal Agents - adverse effects | Cornea | Cell Count | Humans | Organ Preservation | Culture Media, Serum-Free - adverse effects | Drug Contamination - prevention & control | Colony Count, Microbial | Endothelium, Corneal - pathology | Candidiasis - microbiology | Microbial Sensitivity Tests | Candidiasis - prevention & control | Candida albicans - drug effects | Chondroitin Sulfates - adverse effects | Complex Mixtures - pharmacology | Endothelium, Corneal - microbiology | Dextrans - pharmacology | Gentamicins - pharmacology | Voriconazole | Culture Media, Serum-Free - pharmacology | Antifungal Agents - pharmacology | Organ Preservation Solutions - adverse effects | Gentamicins - adverse effects | Amphotericin B - pharmacology | Treatment Outcome | Chondroitin Sulfates - pharmacology | Organ Preservation Solutions - pharmacology | Endothelium, Corneal - drug effects | Pyrimidines - pharmacology | Complex Mixtures - adverse effects | Amphotericin B - adverse effects | Triazoles - pharmacology | Pyrimidines - adverse effects | Tissue Donors | Drug Combinations | Candida glabrata - drug effects | Care and treatment | Keratitis | Amphotericin B | Endophthalmitis | Dosage and administration | Diagnosis | Research | Risk factors | Fungal antigens
Journal Article